Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury

被引:85
作者
Doi, Kent [1 ,3 ]
Noiri, Eisei [1 ,3 ]
Maeda-Mamiya, Rui [1 ]
Ishii, Tomoko [1 ]
Negishi, Kousuke [1 ]
Hamasaki, Yoshifumi [1 ]
Fujita, Toshiro [1 ]
Yahagi, Naoki [2 ]
Koide, Hikaru [4 ]
Sugaya, Takeshi [5 ]
Nakamura, Tsukasa [6 ]
机构
[1] Univ Tokyo, Dept Nephrol & Endocrinol, Tokyo, Japan
[2] Univ Tokyo, Dept Emergency & Crit Care Med, Tokyo, Japan
[3] Univ Tokyo, Japan Sci & Technol Agcy, Japan Int Cooperat Agcy, Tokyo, Japan
[4] Koto Hosp, Dept Med, Tokyo, Japan
[5] St Marianna Univ, Dept Hypertens & Nephrol, Kawasaki, Kanagawa, Japan
[6] Shinmat Sudo Cent Gen Hosp, Dept Med, Matsudo, Chiba, Japan
基金
日本学术振兴会;
关键词
L-type fatty acid-binding protein; biomarker; sepsis; cecal ligation and puncture; lipopolysaccharide; acute kidney injury; ACUTE-RENAL-FAILURE; ORGAN FAILURE; PREDICTS MORTALITY; SERUM CREATININE; UNITED-STATES; EPIDEMIOLOGY; DYSFUNCTION; EXCRETION; INSIGHTS; MODELS;
D O I
10.1097/CCM.0b013e3181eedac0
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: This study is aimed to examine whether urinary L-type fatty acid-binding protein can detect the severity of sepsis with animal sepsis models and septic shock patients complicated with established acute kidney injury. Design: Experimental animal models and a clinical, prospective observational study. Setting: University laboratory and tertiary hospital. Subjects and Patients: One hundred fourteen human L-type fatty acid-binding protein transgenic mice and 145 septic shock patients with established acute kidney injury. Interventions: Animals were challenged by abdominal (cecal ligation and puncture) and pulmonary (intratracheal lipopolysaccharide injection) sepsis models with different severities that were confirmed by survival analysis (n = 24) and bronchoalveolar lavage fluid analysis (n = 38). Measurements and Main Results: In animal experiments, significant increases of urinary L-type fatty acid-binding protein levels were induced by sepsis (severe cecal ligation and puncture 399.0 +/- 226.8 mu g/g creatinine [n = 12], less-severe cecal ligation and puncture 89.1 +/- 25.3 [n = 11], sham 13.4 +/- 3.4 [n = 10] at 6 hrs, p < .05 vs. sham; 200 mu g of lipopolysaccharide 190.6 +/- 77.4 mu g/g creatinine [n = 6], 50 mu g of lipopolysaccharide 145.4 +/- 32.6 [n = 8], and saline 29.9 +/- 14.9 [n = 5] at 6 hrs, p < .05 vs. saline). Urinary L-type fatty acid-binding protein predicted severity more accurately than blood urea nitrogen, serum creatinine, and urinary N-acetyl-D-glucosaminidase levels. In clinical evaluation, urinary L-type fatty acid-binding protein measured at admission was significantly higher in the nonsurvivors of septic shock with established acute kidney injury than in the survivors (4366 +/- 192 mu g/g creatinine [n = 68] vs. 483 +/- 71 [n = 77], p < .05). Urinary L-type fatty acid-binding protein showed the higher value of area under the receiver operating characteristic curve for mortality compared with Acute Physiology and Chronic Health Evaluation (APACHE) II and Sepsis-related Organ Failure Assessment (SOFA) scores (L-type fatty acid-binding protein 0.994 [0.956-0.999], APACHE II 0.927 [0.873-0.959], and SOFA 0.813 [0.733-0.873], p < .05). Conclusions: Our results suggest that urinary L-type fatty acid-binding protein can be a useful biomarker for sepsis complicated with acute kidney injury for detecting its severity. (Crit Care Med 2010; 38: 2037-2042)
引用
收藏
页码:2037 / 2042
页数:6
相关论文
共 35 条
  • [1] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
    Angus, DC
    Linde-Zwirble, WT
    Lidicker, J
    Clermont, G
    Carcillo, J
    Pinsky, MR
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (07) : 1303 - 1310
  • [2] TREATMENT OF SEPSIS BY EXTRACORPOREAL ELIMINATION OF ENDOTOXIN USING POLYMYXIN B-IMMOBILIZED FIBER
    AOKI, H
    KODAMA, M
    TANI, T
    HANASAWA, K
    [J]. AMERICAN JOURNAL OF SURGERY, 1994, 167 (04) : 412 - 417
  • [3] Urinary biomarkers in septic acute kidney injury
    Bagshaw, Sean M.
    Langenberg, Christoph
    Haase, Michael
    Wan, Li
    May, Clive N.
    Bellomo, Rinaldo
    [J]. INTENSIVE CARE MEDICINE, 2007, 33 (07) : 1285 - 1296
  • [4] Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
    Bellomo, R
    Ronco, C
    Kellum, JA
    Mehta, RL
    Palevsky, P
    [J]. CRITICAL CARE, 2004, 8 (04): : R204 - R212
  • [5] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [6] Low baseline serum creatinine concentration predicts mortality in critically ill patients independent of body mass index
    Cartin-Ceba, Rodrigo
    Afessa, Bekele
    Gajic, Ognjen
    [J]. CRITICAL CARE MEDICINE, 2007, 35 (10) : 2420 - 2423
  • [7] In severe acute kidney injury, a higher serum creatinine is paradoxically associated with better patient survival
    Cerda, Jorge
    Cerda, Magdalena
    Kilcullen, Patricia
    Prendergast, Jayne
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (10) : 2781 - 2784
  • [8] Biomarkers for the diagnosis and risk stratification of acute kidney injury: A systematic review
    Coca, S. G.
    Yalavarthy, R.
    Concato, J.
    Parikh, C. R.
    [J]. KIDNEY INTERNATIONAL, 2008, 73 (09) : 1008 - 1016
  • [9] AP214, an analogue of α-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality
    Doi, K.
    Hu, X.
    Yuen, P. S. T.
    Leelahavanichkul, A.
    Yasuda, H.
    Kim, S. M.
    Schnermann, J.
    Jonassen, T. E. N.
    Frokiaer, J.
    Nielsen, S.
    Star, R. A.
    [J]. KIDNEY INTERNATIONAL, 2008, 73 (11) : 1266 - 1274
  • [10] Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice
    Doi, K
    Okamoto, K
    Negishi, K
    Suzuki, Y
    Nakao, A
    Fujita, T
    Toda, A
    Yokomizo, T
    Kita, Y
    Kihara, Y
    Ishii, S
    Shimizu, T
    Noiri, E
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2006, 168 (05) : 1413 - 1424